Emerging markets

Rodier et al 2020 – Use of the CPP in 18 maturing markets

Background: The certificate of pharmaceutical product (CPP) was implemented to accelerate the availability of new drugs in developing countries by providing evidence of the quality of products and reducing [...]

2021-01-29T09:17:11+00:00July 7th, 2020|Tags: , |

CIRS RD Briefing 51 – Submission lag time in the emerging markets

Lag Time (the time from which a product has been granted market authorisation in its first market to the time that its application is submitted for review by an [...]

2021-01-29T09:14:15+00:00August 29th, 2012|Tags: , |
Go to Top